Journal article

Transactivation-deficient p73 alpha (p73 Delta exon2) inhibits apoptosis and competes with p53

I Fillippovich, N Sorokina, M Gatei, Y Haupt, K Hobson, E Moallem, K Spring, M Mould, MA McGuckin, MF Lavin, KK Khanna

Oncogene | NATURE PUBLISHING GROUP | Published : 2001

DOI: 10.1038/sj.onc.1204118

Citation metrics

110Web of Science
114Scopus

Keywords

Wild-Type P53
Transactivation
Fas Receptor
Breast Neoplasms
P53
Rna, Messenger
Tumor Suppressor Proteins
Transcriptional Activation
Nuclear Proteins
Tumor Protein P73
Dna-Binding Proteins
Antigens, Cd95
P73 Gene
Alternative Splicing
Dna-Damage
Kinase C-Abl
Genes, Tumor Suppressor
Rna, Neoplasm
Life Sciences & Biomedicine
Humans
Ataxia-Telangiectasia
Apoptosis
Breast Cancer
P73
Biochemistry & Molecular Biology
Tumor Suppressor Protein P53
Drug-Induced Apoptosis
Oncology
Science & Technology
Mammalian-Cells
Mediated Apoptosis
Female
Tumor Cells, Cultured
Apo-1/fas Receptor/ligand System
Cisplatin
Cell Biology
Burkitts-Lymphoma Cells
Genetics & Heredity